ECM
PRLD icon

ExodusPoint Capital Management’s Prelude Therapeutics PRLD Stock Holding History

ExodusPoint Capital Management’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-921,621
Closed -$1.91M – 1968
2024
Q3 		$1.91M Buy
+921,621
New +$4.27M 0.02% 755
2022
Q1 		– Sell
-20,773
Closed -$259K – 2584
2021
Q4 		$259K Buy
+20,773
New +$338K ﹤0.01% 1715
2020
Q4 		– Sell
-7,108
Closed -$214K – 2315
2020
Q3 		$214K Buy
+7,108
New +$201K 0.01% 1445

Other funds holding PRLD

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return